TXCELL IS NOW A SANGAMO COMPANY. PLEASE VISIT SANGAMO.COM
Location: France, Provence-Alpes-Cote d'Azur, Nice
Total raised: $16.09M
Founded date: 2001
Investors 1
| Date | Name | Website |
| - | Auriga Par... | auriga.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.11.2012 | - | $16.09M | - |
Mentions in press and media 3
| Date | Title | Description |
| 15.09.2024 | Dialogue with CGT Leaders! You Are Invited to Join the "2024 GenScript Biotech Global Forum•London" to Discuss the Future Together | PISCATAWAY, N.J., Sept. 15, 2024 /PRNewswire/ -- The year 2024 marks a milestone year for continuous advancements in Cell and Gene Therapy (CGT). The global launch of Amtagvi, a Tumor-Infiltrating Lymphocyte (TIL) therapy, has ushered in a ... |
| 26.11.2012 | TxCell Raises €12.4M in Third Financing | TxCell SA, a France-based biotechnology company developing cell-based immunotherapies for the treatment of severe chronic inflammatory diseases, raised €12.4m in a third financing. Backers include the InnoBio fund, managed by CDC Entreprise... |
| 06.03.2008 | Life-science briefing: Thursday, March 6, 2008 | TODAY’S HEADLINES: France’s TxCell raises €11M for cell therapy (release) Healthcare IT firm TriHealix takes in $7M (release) Healthcare-software provider Anodyne Health acquires Piedmont Healthcare (release) CEO, CFO resign at inhaled-drug... |